论文信息 - ESPAC-3(v2): A multicenter, international, open-label, randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma. - 字舞流文

ESPAC-3(v2): A multicenter, international, open-label, randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma.

D. Smith | J. Neoptolemos | D. Stocken | C. Bassi | D. Goldstein | D. Cunningham | P. Ghaneh | M. Büchler | C. Dervenis | M. Buchler | M. Moore | D. Smith | J. Neoptolemos | Deborah D. Stocken | David Cunningham | M. Buchler | David Smith | D. Stocken